Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4356.4% | +1644.5% | 3 / 3 | +1.7% | +0.09 pp | +14.03 pp | +14.1% | 2.03 | 8.29 | 65,7 | +1,7% | 9,4 | +4.445,6% | 8.29 | 10.49 | −20,9% |
| Pts | 12 | 12 | 12 | 0 | 8 | 12 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 16.100 (close price on 2026-10-19)EPS (TTM): 1.941
Financial charts
1.Revenue & growth
VND bn65,7Q2/26
1.Revenue & growth
VND bn65,7Q2/26
2.Profit & growth
VND bn9,24Q2/26
3.Profit mix (Penman)
VND bn40,8Q2/26
4.Margins & cost structure
%45.3%Q2/26
5.Returns & cash cycle
% · days8.4%Q2/26
6.Earnings quality & cash
VND bn93,0Q2/26
7.Asset structure
VND bn788Q2/26
8.Funding & debt health
VND bn · times788Q2/26
9.Revenue backlog
VND bn6,22Q2/26
10.Valuation
times · %8,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %577Q2/26
Adjusted EPS growth, latest quarter
44,6× higher
Average adjusted EPS growth, 3 quarters
17,4× higher
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26